BOULDER, Colo., Jan. 12, 2026 /PRNewswire/ -- Mandara Biopharma Inc., a privately held U.S.-based biopharmaceutical company focused on novel therapies for central nervous system (CNS) disorders, today ...
Boulder-based Mandara has entered the growing CBD-product market, but the company is trying to set itself apart with an approach that focuses as much on consumer education as it does on sales. Mandara ...
WILMINGTON, Del.--(BUSINESS WIRE)--Positive high-level results from the MANDARA Phase III trial showed AstraZeneca’s FASENRA (benralizumab) met the primary endpoint of the trial and demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results